Comprehensive Evaluation of Genetic and Environmental Factors Influencing the Plasma Lipoprotein-Associated Phospholipase A2 Activity in a Japanese Population
- 1 January 2007
- journal article
- Published by Japanese Society of Hypertension in Hypertension Research
- Vol. 30 (5) , 403-409
- https://doi.org/10.1291/hypres.30.403
Abstract
Hypertension Research, official publication of the Japanese Society of Hypertension, publishes papers reporting original clinical and experimental research in the field of hypertension and related cardiovascular diseases.Keywords
This publication has 27 references indexed in Scilit:
- Lipoprotein-Associated Phospholipase A 2 Is an Independent Marker for Coronary Endothelial Dysfunction in HumansArteriosclerosis, Thrombosis, and Vascular Biology, 2006
- Association between Lp-PLA2 and coronary artery disease: Focus on its relationship with lipoproteins and markers of inflammation and hemostasisAtherosclerosis, 2005
- Metabolic Syndrome and Cardiac Disease in Japanese Men: Applicability of the Concept of Metabolic Syndrome Defined by the National Cholesterol Education Program-Adult Treatment Panel III to Japanese Men-The Tanno and Sobetsu StudyHypertension Research, 2005
- Association of Lipoprotein-Associated Phospholipase A 2 Mass and Activity With Calcified Coronary Plaque in Young AdultsArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Adenovirus-mediated gene transfer of Lp-PLA2 reduces LDL degradation and foam cell formation in vitroJournal of Lipid Research, 2004
- Functional impairment of two novel mutations detected in lipoprotein-associated phospholipase A2 (Lp-PLA2) deficiency patientsJournal of Human Genetics, 2004
- Platelet-activating factor-acetylhydrolase and PAF-receptor gene haplotypes in relation to future cardiovascular event in patients with coronary artery diseaseHuman Molecular Genetics, 2004
- Plasma PAF-acetylhydrolase in patients with coronary artery disease: results of a cross-sectional analysisJournal of Lipid Research, 2003
- A Mutation in Plasma Platelet-Activating Factor Acetylhydrolase (Val 279 →Phe) is a Genetic Risk Factor for StrokeStroke, 1997
- Activity of platelet-activating factor (PAF) acetylhydrolase in plasma from healthy habitual cigarette smokersHeart and Vessels, 1990